The relationship between SARS-CoV-2 infection history and persistent symptoms in a rural Wisconsin community cohort
Year: 2026
Type: article
Abstract: Some individuals experience persistent symptoms after COVID-19 (“Long COVID”). We assessed persistent symptoms consistent with Long COVID by SARS-CoV-2 infection history. Participants of a longitudinal, community-based cohort completed a survey about new persistent symptoms starting on/after January 2022. Cox models assessed relative hazards of symptoms among those with Omicron-only infection, or Omicron plus pre-Omicron infection, versus no infection. Models controlled for age group (18–49 versus ≥ 50 years), sex, and chronic health conditions as time-fixed effects and vaccination status as time-varying. Of 646 respondents, 61% were female; 66% were ≥ 50 years old. The presence of ≥ 1 new persistent symptom was 37% (107/287), 41% (124/303), and 43% (24/56) among individuals with no infection, Omicron-only infection, and Omicron plus pre-Omicron infection, respectively. Individuals with Omicron-only infection had increased, non-significant hazards of new persistent symptoms (aHR: 1.23, 95% CI: 0.94–1.61) compared to individuals with no infection. Individuals with Omicron plus pre-Omicron infection had increased, statistically significant hazards of new persistent symptoms (aHR: 1.94, 95% CI: 1.33–2.83) compared to no infection. During the Omicron variant period, SARS-CoV-2 reinfection was associated with new persistent symptoms in adults. Primary infection was not statistically significantly associated with new persistent symptoms compared to those not infected.
Source: Scientific Reports
Institutions: Marshfield Clinic, Centers for Disease Control and Prevention
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7237360147
